Mycobacterium tuberculosis disease associates with higher HIV-1-specific antibody responses

被引:2
作者
Adeoye, Bukola [1 ]
Nakiyingi, Lydia [2 ]
Moreau, Yvetane [3 ]
Nankya, Ethel [4 ]
Olson, Alex J. [3 ]
Zhang, Mo [3 ]
Jacobson, Karen R. [3 ]
Gupta, Amita [5 ]
Manabe, Yukari C. [5 ]
Hosseinipour, Mina C. [6 ]
Kumwenda, Johnstone [7 ]
Sagar, Manish [1 ,3 ]
机构
[1] Boston Univ, Dept Microbiol, Sch Med, Boston, MA 02118 USA
[2] Makerere Univ, Infect Dis Inst, Coll Hlth Sci, Kampala, Uganda
[3] Boston Med Ctr, Dept Med, Boston, MA 02118 USA
[4] Boston Univ, Div Computat Biomed, Sch Med, Boston, MA 02118 USA
[5] Johns Hopkins Univ, Dept Med, Sch Med, Baltimore, MD USA
[6] Univ N Carolina, Sch Med, Chapel Hill, NC USA
[7] Univ Malawi, Coll Med, Blantyre, Malawi
基金
美国国家卫生研究院;
关键词
IMMUNODEFICIENCY-VIRUS TYPE-1; NEUTRALIZING ANTIBODIES; HETEROLOGOUS IMMUNITY; T-CELLS; B-CELLS; HIV-1; INFECTION; VACCINE; INFLAMMATION; INDIVIDUALS;
D O I
10.1016/j.isci.2023.106631
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Mycobacterium tuberculosis (Mtb) is the most common infection among people with HIV (PWH). Mtb disease-associated inflammation could affect HIV-directed immune responses in PWH. We show that HIV antibodies are broader and more potent in PWH in the presence as compared to the absence of Mtb disease. With co-existing Mtb disease, the virus in PWH also encounters unique antibody selection pressure. The Mtb-linked HIV antibody enhancement associates with specific mediators important for B cell and antibody development. This Mtb humoral augmentation does not occur due to cross-reactivity, a generalized in-crease in all antibodies, or differences in duration or amount of antigen exposure. We speculate that the co-localization of Mtb and HIV in lymphatic tissues leads to the emergence of potent HIV antibodies. PWH's Mtb disease status has implica-tions for the future use of HIV broadly neutralizing antibodies as prophylaxis or treatment and the induction of better humoral immunity.
引用
收藏
页数:22
相关论文
共 50 条
[11]   Immune modulation and reconstitution of HIV-1-specific responses: Novel approaches and strategies [J].
Burton, C. T. ;
Mela, C. M. ;
Rosignoli, G. ;
Westrop, S. J. ;
Gotch, F. M. ;
Imami, N. .
CURRENT MEDICINAL CHEMISTRY, 2006, 13 (26) :3203-3211
[12]   HIV-1-specific functional immune measurements as markers of disease progression [J].
Moss, RB ;
Richieri, SP ;
Ferre, F ;
Daigle, AE ;
Trauger, R ;
Theofan, G ;
Giermakowska, W ;
Lanza, P ;
Brostoff, S ;
Carlo, DJ ;
Jensen, FC .
JOURNAL OF BIOMEDICAL SCIENCE, 1997, 4 (04) :127-131
[13]   Dynamic antibody responses to the Mycobacterium tuberculosis proteome [J].
Kunnath-Velayudhan, Shajo ;
Salamon, Hugh ;
Wang, Hui-Yun ;
Davidow, Amy L. ;
Molina, Douglas M. ;
Huynh, Vu T. ;
Cirillo, Daniela M. ;
Michel, Gerd ;
Talbot, Elizabeth A. ;
Perkins, Mark D. ;
Felgner, Philip L. ;
Liang, Xiaowu ;
Gennaro, Maria L. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (33) :14703-14708
[14]   Can HIV-1-specific ADCC assist the clearance of reactivated latently infected cells? [J].
Lee, Wen Shi ;
Parsons, Matthew Sidney ;
Kent, Stephen John ;
Lichtfuss, Marit .
FRONTIERS IN IMMUNOLOGY, 2015, 6
[15]   Persistent HIV-1-specific cellular responses despite prolonged therapeutic viral suppression [J].
Appay, V ;
Hansasuta, P ;
Sutton, J ;
Schrier, RD ;
Wong, JK ;
Furtado, M ;
Havlir, DV ;
Wolinsky, SM ;
McMichael, AJ ;
Richman, DD ;
Rowland-Jones, SL ;
Spinha, CA .
AIDS, 2002, 16 (02) :161-170
[16]   Induction of Broad and Polyfunctional HIV-1-Specific T Cell Responses by the Multiepitopic Protein TMEP-B Vectored by MVA Virus [J].
Perdiguero, Beatriz ;
Sanchez-Corzo, Cristina ;
Sorzano, Carlos Oscar S. ;
Mediavilla, Pilar ;
Saiz, Lidia ;
Esteban, Mariano ;
Elena Gomez, Carmen .
VACCINES, 2019, 7 (03)
[17]   HIV-1-Specific Cytotoxic T Lymphocytes and Breast Milk HIV-1 Transmission [J].
John-Stewart, Grace C. ;
Mbori-Ngacha, Dorothy ;
Payne, Barbara Lohman ;
Farquhar, Carey ;
Richardson, Barbra A. ;
Emery, Sandra ;
Otieno, Phelgona ;
Obimbo, Elizabeth ;
Dong, Tao ;
Slyker, Jennifer ;
Nduati, Ruth ;
Overbaugh, Julie ;
Rowland-Jones, Sarah .
JOURNAL OF INFECTIOUS DISEASES, 2009, 199 (06) :889-898
[18]   Induction of HIV-1-Specific Mucosal Immune Responses Following Intramuscular Recombinant Adenovirus Serotype 26 HIV-1 Vaccination of Humans [J].
Baden, Lindsey R. ;
Liu, Jinyan ;
Li, Hualin ;
Johnson, Jennifer A. ;
Walsh, Stephen R. ;
Kleinjan, Jane A. ;
Engelson, Brian A. ;
Peter, Lauren ;
Abbink, Peter ;
Milner, Danny A., Jr. ;
Golden, Kevin L. ;
Viani, Kyle L. ;
Stachler, Matthew D. ;
Chen, Benjamin J. ;
Pau, Maria G. ;
Weijtens, Mo ;
Carey, Brittany R. ;
Miller, Caroline A. ;
Swann, Edith M. ;
Wolff, Mark ;
Loblein, Hayley ;
Seaman, Michael S. ;
Dolin, Raphael ;
Barouch, Dan H. .
JOURNAL OF INFECTIOUS DISEASES, 2015, 211 (04) :518-528
[19]   Induction of systemic HIV-1-specific cellular immune responses by oral exposure in the uninfected partner of discordant couples [J].
Perez, Carina L. ;
Hasselrot, Klara ;
Bratt, Goran ;
Broliden, Kristina ;
Karlsson, Annika C. .
AIDS, 2010, 24 (07) :969-974
[20]   Advances in HIV-1-specific chimeric antigen receptor cells to target the HIV-1 reservoir [J].
Choudhary, Madhu C. ;
Cyktor, Joshua C. ;
Riddler, Sharon A. .
JOURNAL OF VIRUS ERADICATION, 2022, 8 (02)